Cramer Rosenthal McGlynn

CRM manages concentrated, value-oriented US equity portfolios with a focus on small- to mid-cap companies. The firm runs both long-only and long-short strategies, using deep fundamental research and a catalyst-driven approach — such as corporate restructurings, management changes, or industry consolidation — to identify mispriced securities. Its investment horizon tends to be multi-year, consistent with a private-equity-style due-diligence process applied to public markets.

Investment decisions are made by CRM's portfolio management team, led by senior partners including CEO Jay Abramson and colleagues who have spent the bulk of their careers at the firm. CRM's partnership structure concentrates decision-making authority within a small group of senior investors rather than dispersing it across a large, multi-tiered analyst pool, a model that has defined the firm's investment process since its founding.

CRM remains an independent, employee-owned firm. Unlike many of its contemporaries founded in the 1970s, CRM has not sold to a bank, insurance platform, multi-boutique aggregator, or private equity group. This independence ties the investment team's compensation and firm economics to long-term portfolio outcomes rather than asset-gathering targets or corporate parent initiatives.

CRM's value framework naturally orients the portfolio toward sectors where mispricing and cyclical dislocations occur. Historical and current exposures have concentrated in Financial Services, Technology, Healthcare, and Industrial cyclicals. The firm does not self-limit to these sectors but has built its research depth in areas where balance-sheet complexity or regulatory change can suppress valuations.

CRM relies on proprietary, bottom-up fundamental research — company filings, industry data, field-level interviews, and frequent direct engagement with management teams — rather than sell-side coverage or quantitative screens. The firm targets situations where a catalyst (a spin-off, a new management team, a post-merger integration) is likely to surface unrecognized value within a 12- to 36-month window.

CRM has historically served as a sub-adviser for insurance general accounts and mutual fund series trusts, and it offers its strategies through institutional separate accounts and commingled vehicles. However, the firm has not launched private equity funds, venture arms, or credit strategies under its own brand, and its public identity remains tightly defined by equity value investing.

CRM has historically prioritized investment capacity discipline over rapid asset growth. By focusing on small- and mid-cap equities — where larger mandate sizes can degrade strategy effectiveness — the firm has tended to close strategies or limit new inflows when it believes additional assets would constrain its opportunity set, although specific closure thresholds are not publicly disclosed.